The cost of drug development.
dc.contributor.author | DiMasi, Joseph A | |
dc.contributor.author | Grabowski, Henry G | |
dc.contributor.author | Hansen, Ronald W | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2016-09-13T07:48:34Z | |
dc.date.issued | 2015-05-14 | |
dc.identifier | ||
dc.identifier.eissn | 1533-4406 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Massachusetts Medical Society | |
dc.relation.ispartof | N Engl J Med | |
dc.relation.isversionof | 10.1056/NEJMc1504317 | |
dc.subject | Drug Costs | |
dc.subject | Drug Discovery | |
dc.subject | Drug Industry | |
dc.subject | Financing, Government | |
dc.title | The cost of drug development. | |
dc.type | Journal article | |
pubs.author-url | ||
pubs.begin-page | 1972 | |
pubs.issue | 20 | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Economics | |
pubs.organisational-group | Trinity College of Arts & Sciences | |
pubs.publication-status | Published | |
pubs.volume | 372 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- DiMasi et al NEJM letter_May 14_2015.pdf
- Size:
- 275.66 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version